What do Cochrane systematic reviews say about interventions for retinal vein occlusion
Abstract Purpose: To summarize the evidence from Cochrane systematic reviews on interventions for Central or Branch Vein Occlusion. Methods: We included and summarized the results from Cochrane systematic reviews on interventions for both types of occlusion. The initial search retrieved was 21 rev...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Oftalmologia
2020-09-01
|
| Series: | Revista Brasileira de Oftalmologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/pdf/rbof/v79n4/0034-7280-rbof-79-04-0248.pdf |
| _version_ | 1798026459779956736 |
|---|---|
| author | Vânia Mozetic Natasha Ferreira Santos da Cruz Matheus Ferreira Santos da Cruz Murilo Ubukata Polizelli Nilva Simeren Bueno de Moraes |
| author_facet | Vânia Mozetic Natasha Ferreira Santos da Cruz Matheus Ferreira Santos da Cruz Murilo Ubukata Polizelli Nilva Simeren Bueno de Moraes |
| author_sort | Vânia Mozetic |
| collection | DOAJ |
| description | Abstract Purpose: To summarize the evidence from Cochrane systematic reviews on interventions for Central or Branch Vein Occlusion. Methods: We included and summarized the results from Cochrane systematic reviews on interventions for both types of occlusion. The initial search retrieved was 21 reviews and four of them were selected. Results: The four systematic reviews included evaluated the effects of laser techniques and intravitreal injections of Anti-Vascular Endothelial Growth Factor (anti-VEGF) and corticosteroids on Branch and Central Retinal Vein Occlusions. Conclusions: In Branch Retinal Vein Occlusion was found some benefits in the use of grid laser when comparable to no intervention but insufficient evidence about the use of early grid laser, subthreshold laser, intravitreal triamcinolone or anti-VEGF over macular grid laser photocoagulation. In Central Retinal Vein Occlusion with Macular Edema was found insufficient evidence to determine the benefits of intravítreo steroids but ranibizumab may improve clinical and visual outcomes at six and 12 months and repeated intravitreal injection of anti-VEGF agents improved visual outcomes at six months when compared to no treatment. |
| first_indexed | 2024-04-11T18:36:49Z |
| format | Article |
| id | doaj.art-cc9c10ecaaae499faec0629f9c37ccf1 |
| institution | Directory Open Access Journal |
| issn | 1982-8551 |
| language | English |
| last_indexed | 2024-04-11T18:36:49Z |
| publishDate | 2020-09-01 |
| publisher | Sociedade Brasileira de Oftalmologia |
| record_format | Article |
| series | Revista Brasileira de Oftalmologia |
| spelling | doaj.art-cc9c10ecaaae499faec0629f9c37ccf12022-12-22T04:09:16ZengSociedade Brasileira de OftalmologiaRevista Brasileira de Oftalmologia1982-85512020-09-0179424825210.5935/0034-7280.20200053What do Cochrane systematic reviews say about interventions for retinal vein occlusionVânia Mozetichttps://orcid.org/0000-0002-6243-1530Natasha Ferreira Santos da Cruzhttps://orcid.org/0000-0002-5209-9204Matheus Ferreira Santos da Cruzhttps://orcid.org/0000-0002-2223-4815Murilo Ubukata Polizellihttps://orcid.org/0000-0003-2429-216XNilva Simeren Bueno de Moraeshttps://orcid.org/0000-0001-5605-6028Abstract Purpose: To summarize the evidence from Cochrane systematic reviews on interventions for Central or Branch Vein Occlusion. Methods: We included and summarized the results from Cochrane systematic reviews on interventions for both types of occlusion. The initial search retrieved was 21 reviews and four of them were selected. Results: The four systematic reviews included evaluated the effects of laser techniques and intravitreal injections of Anti-Vascular Endothelial Growth Factor (anti-VEGF) and corticosteroids on Branch and Central Retinal Vein Occlusions. Conclusions: In Branch Retinal Vein Occlusion was found some benefits in the use of grid laser when comparable to no intervention but insufficient evidence about the use of early grid laser, subthreshold laser, intravitreal triamcinolone or anti-VEGF over macular grid laser photocoagulation. In Central Retinal Vein Occlusion with Macular Edema was found insufficient evidence to determine the benefits of intravítreo steroids but ranibizumab may improve clinical and visual outcomes at six and 12 months and repeated intravitreal injection of anti-VEGF agents improved visual outcomes at six months when compared to no treatment.http://www.scielo.br/pdf/rbof/v79n4/0034-7280-rbof-79-04-0248.pdfRetinal vein occlusionCentral or rranch retinal vein occlusionTherapeuticsEvidence-based practiceEvidence-based medicine |
| spellingShingle | Vânia Mozetic Natasha Ferreira Santos da Cruz Matheus Ferreira Santos da Cruz Murilo Ubukata Polizelli Nilva Simeren Bueno de Moraes What do Cochrane systematic reviews say about interventions for retinal vein occlusion Revista Brasileira de Oftalmologia Retinal vein occlusion Central or rranch retinal vein occlusion Therapeutics Evidence-based practice Evidence-based medicine |
| title | What do Cochrane systematic reviews say about interventions for retinal vein occlusion |
| title_full | What do Cochrane systematic reviews say about interventions for retinal vein occlusion |
| title_fullStr | What do Cochrane systematic reviews say about interventions for retinal vein occlusion |
| title_full_unstemmed | What do Cochrane systematic reviews say about interventions for retinal vein occlusion |
| title_short | What do Cochrane systematic reviews say about interventions for retinal vein occlusion |
| title_sort | what do cochrane systematic reviews say about interventions for retinal vein occlusion |
| topic | Retinal vein occlusion Central or rranch retinal vein occlusion Therapeutics Evidence-based practice Evidence-based medicine |
| url | http://www.scielo.br/pdf/rbof/v79n4/0034-7280-rbof-79-04-0248.pdf |
| work_keys_str_mv | AT vaniamozetic whatdocochranesystematicreviewssayaboutinterventionsforretinalveinocclusion AT natashaferreirasantosdacruz whatdocochranesystematicreviewssayaboutinterventionsforretinalveinocclusion AT matheusferreirasantosdacruz whatdocochranesystematicreviewssayaboutinterventionsforretinalveinocclusion AT muriloubukatapolizelli whatdocochranesystematicreviewssayaboutinterventionsforretinalveinocclusion AT nilvasimerenbuenodemoraes whatdocochranesystematicreviewssayaboutinterventionsforretinalveinocclusion |